SLU-PP-332: The Complete Research Protocol

Disclaimer: This article is for educational and research purposes only. SLU-PP-332 is an ERR (Estrogen-Related Receptor) agonist and is currently in the research and development phase. It is not approved by the FDA for human consumption. All information reflects current biochemical literature and animal study data.

What is SLU-PP-332?

SLU-PP-332 is a first-in-class small molecule ERR agonist (specifically targeting ERRα, ERRβ, and ERRγ). In the research community, it is frequently referred to as an "Exercise Mimetic" or "exercise in a pill."

Unlike traditional peptides that signal the pituitary gland (like CJC-1295), SLU-PP-332 works directly on skeletal muscle metabolism to simulate the physiological effects of endurance training without physical exertion.

• Primary Action: Enhances oxidative capacity in skeletal muscle.
• Key Effect: Promotes the burning of fat stores while preserving lean muscle mass.
• Molecular Weight: 483.5 g/mol
• Target: Estrogen-Related Receptors (ERRs)

Mechanism of Action

SLU-PP-332 functions by activating a genetic program typically triggered by aerobic exercise:

• Mitochondrial Biogenesis: Increases the density and efficiency of mitochondria (the "powerhouses" of the cell).
• Fatty Acid Oxidation: Shifts the body's primary fuel source from glucose (sugar) to lipids (fat).
• Fiber Type Switching: Research suggests it may help shift muscle fibers toward Type I (slow-twitch), which are more resistant to fatigue.

Current Research Landscape

Summary of Findings (Animal Studies)

Research Protocols

Note: Because SLU-PP-332 is a newer compound, human-equivalent doses (HED) are based on animal-to-human scaling calculations.

Critical Research Note: Unlike CJC/Ipamorelin, SLU-PP-332 does not rely on GH pulses. Therefore, it does not necessarily require strict fasting, although it is often studied in a fasted state to maximize fatty acid oxidation.

Reconstitution & Administration (5mg Vial)

Since SLU-PP-332 is often provided in 5mg vials, but researched at higher milligram dosages, researchers must be precise with their math.

Step-by-Step Reconstitution

1. Sanitize: Clean the vial stopper with 70% isopropyl alcohol.
2. Draw: Pull 1 mL of Bacteriostatic Water or a specialized solvent (some research forms require PEG or DMSO depending on the lab's formulation).
3. Inject: Slowly add the liquid to the 5mg vial.
4. Dissolve: Swirl gently until the solution is clear.

Concentration Reference (5mg Vial / 1mL Water)

• Full Vial: 5,000 mcg (5 mg)
• 0.10 mL (10 Units): 500 mcg (0.5 mg)
• 0.20 mL (20 Units): 1,000 mcg (1 mg)

Here is the breakdown for a 2 mL reconstitution, which is generally easier to measure for this specific math.

SLU-PP-332 Dosing Guide (5 mg Vial)

Vial Total: 5 mg (5,000 mcg)

Water Added: 2 mL (200 units)

Concentration: 2.5 mg per 1 mL (25 mcg per unit)

Your Target Dose: 2 mg (2,000 mcg)

To get exactly 2 mg, you will draw to the 80 Unit mark on a standard 100-unit (1 mL) insulin syringe.

Critical Research Considerations for SLU-PP-332

• Solubility Check: SLU-PP-332 is a "small molecule" compound. Depending on the lab's specific formulation, it can sometimes be "stubborn" to dissolve in plain Bacteriostatic Water. If you see particles floating after 10 minutes of swirling, let it sit in the fridge for an hour; they usually dissolve on their own.
• The "Exercise Timing" Theory: While the drug mimics exercise, some research suggests that administering it in the morning (mimicking the start of a day's activity) may better align with the body's natural circadian metabolic rhythms.
• Stacking Logic: If you are running this alongside your CJC/Ipamorelin blend:
  • CJC/Ipam: Best at Night (for GH pulses).
  • SLU-PP-332: Best in the Morning (for metabolic/fat-burning signaling).

Supply Note:

Since your daily dose is 2 mg and the vial is 5 mg, you will get exactly 2.5 doses per vial.

• Day 1: 80 Units
• Day 2: 80 Units
• Day 3: The remaining 40 Units (You will need to open a second vial to pull the other 40 Units to complete the dose).

Knowledge Gaps & Limitations

Frequently Asked Questions

• Does SLU-PP-332 cause jitters like caffeine? No. It is not a central nervous system stimulant; it acts on cellular metabolism, not the heart rate or adrenals.
• Can it be stacked with CJC-1295/Ipamorelin? In research settings, yes. They target different systems (GH vs. Metabolic ERR), which can lead to a comprehensive "recomposition" effect.
• Is it "stable" at room temperature? Like most peptides, the lyophilized powder is stable, but once reconstituted, it should be kept refrigerated and used within 30 days.